4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling. 2006

Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
Department of Organic Chemistry, Lund University, P.O.B. 124, SE-221 00 Lund, Sweden.

The 3-ethoxycarbonyl-4-quinolone compound 1 has previously been identified via a database search as an interesting lead compound for ligand binding at the benzodiazepine site of GABA(A) receptors (Kahnberg et al. J. Mol. Graphics Modelling 2004, 23, 253-261). Pharmacophore-guided optimization of this lead compound yielded a number of high-affinity ligands for the benzodiazepine site including compounds 20 and 23-25 displaying sub-nanomolar affinities. A few of the compounds have been tested on the alpha(1)beta(2)gamma(2S) and alpha(3)beta(2)gamma(2S) GABA(A) receptor subtypes, and two of the compounds (5 and 19) display selectivity for alpha(1)- versus alpha(3)-containing receptors by a factor of 22 and 27, respectively. This selectivity for alpha(1)beta(2)gamma(2S) is in the same range as that for the well-known alpha(1) subunit selective compound zolpidem.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
July 2009, Medicinal chemistry (Shariqah (United Arab Emirates)),
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
January 2011, Bioorganic & medicinal chemistry,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
July 2008, Bioorganic & medicinal chemistry,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
July 1999, Neuroscience letters,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
November 2008, Bioorganic & medicinal chemistry letters,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
December 2012, European journal of medicinal chemistry,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
January 1992, European journal of pharmacology,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
February 2012, Bioorganic chemistry,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
January 2011, Current topics in medicinal chemistry,
Erik Lager, and Pierre Andersson, and Jakob Nilsson, and Ingrid Pettersson, and Elsebet Østergaard Nielsen, and Mogens Nielsen, and Olov Sterner, and Tommy Liljefors
April 2005, Journal of medicinal chemistry,
Copied contents to your clipboard!